The story
Cayman opened a lawful route to prescribed cannabis extracts and tinctures in November 2016. A doctor licensed locally could prescribe them for a patient under that doctor’s care and determine the dose. The change linked patients to authorised doctors, pharmacists and importers.[1]
A prescription changed what patients could use
Cannabis possession and consumption were already criminal offences under the 1973 drug law. The medical reform added an express rule making prescribed extracts and tinctures lawful for medical or therapeutic use. It placed the patient’s treatment and dosage under a licensed medical doctor’s responsibility.[1]
The published bill explained the practical purpose: allowing cannabis oil to be imported and dispensed for medicinal purposes. It proposed a specific group of authorised people, including doctors, pharmacists, retail pharmacies, lawful importers and patients holding the required prescription.[2]
November marks the legal start
The official legislation history records the amendment as enacted on 24 October 2016 and commencing on 18 November. That start date matters when following the route from a legislative decision to lawful treatment.[1]
The permission concerned extracts and tinctures. The general offences covering unauthorised possession, growing, supply and consumption remained part of the drug law. Patients needed the prescribed product and the medical relationship described in the exception.[1]
Imports connected the law to pharmacies
By 29 August 2017, Canadian producer Cronos Group reported that its subsidiary Peace Naturals had completed the company’s first medical-oil shipment to Cayman. The buyer was Caribbean Medical Distributors, working with Professional Pharmacy Services at CTMH Doctors Hospital in George Town.[3]
That announcement identified a concrete supply chain: a Canadian producer, a Cayman distributor and a hospital pharmacy. It showed how an authorised imported product could reach the local medical system after the prescription reform. The company presented the shipment as a new step in its international distribution business.[3]
Recreational reform followed a different route
The later debate concerned people who used or possessed cannabis outside that medical exception. After the April 2025 referendum, Premier André Ebanks told Parliament that voters had backed decriminalisation and that the question would go to the Law Reform Commission.[4]
The commission’s July 2026 consultation focused on recreational possession and use because medical and therapeutic use was already permitted. It asked about quantities, home growing and clearing old convictions. The Cayman profile follows both the existing prescription route and that continuing reform process.[5]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%2 → 2
- Sharing & gifting · 10%1 → 1
- Consumption · 10%0 → 0
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Cayman Islands's current scores.
References
- Cayman Islands — Misuse of Drugs Act (2026 Revision)Sections 2, 2A, 3, 16, 37–44; Schedule 1; legislation history, pp. 55–56archived
- Cayman Islands — Misuse of Drugs (Amendment) Bill, 2016Memorandum and clauses 2–4; published 19 August 2016archived
- Cronos Group — First company shipment of medical cannabis oil to Cayman, 29 August 2017archived
- Cayman Islands Parliament — Premier André Ebanks, answer to Question 19, 27 June 2025Pages 1–2, cannabis referendum result and proposed referralarchived
- Cayman Islands Law Reform Commission — Cannabis Reform discussion paper, 1 July 2026Sections 1–2, 4.2–4.3 and 10; consultation questions 8–10archived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.